Back Stocks profile

Stock analysis tool for investors

Torrent Pharmaceuticals Ltd.

NSE: TORNTPHARM | BSE:500420

₹2856.00 -29.55 (-1.02%) 1D

Pharmaceuticals & Biotechnology

View detailed Technical chart

Open an Account with Bigul in 5 minutes

Performance

Today’s low

2845.20

Today’s High

2899.80

52W low

1772.00

52W High

2980.00

Open Price

2899.80

Prev. Close

2782.0000

Volume

68769.00

Value

196404264.00

Fundamentals

Market Cap Cr

96660.00

Price to Earnings

58.40

Price to Book Value

14.10

Dividend Yield

1.10

PE to Growth

1.70

Op Revenue TTM Cr

10728.00

Net Profit TTM Cr

1656.00

Cash From Operating Activity Cr

3266.00

Return on Equity %

24.15

EMA & SMA

Bullish Moving Averages

14

Bearish Moving Averages

2

DELIVERY AND VOLUME

DAILY AVG. DELIVERY VOLUME %

19 Jun, 2024

44.9

Week

49.6

Month

47

LEGEND

Positive Indicator

Neutral Indicator

Negative Indicator

RESISTANCE AND SUPPORT

2911.17

PIVOT

First Resistance

2954.38

Second Resistance

3023.22

Third Resistance

3066.43

First Support

2842.33

Second Support

2799.12

Third Support

2730.28

Relative Strength Index

67.05

Money Flow Index

77.88

MACD

63.93

MACD Signal

51.97

Average True Range

75.62

Average Directional Index

21.71

Rate of Change (21)

6.6

Rate of Change (125)

37.84

Commodity Channel Index

108.5

Williams %R

-23.1

BETA

1 Month

0.16

3 Month

0.37

1 Year

0.2

3 Year

-0.06

PRICE CHANGE ANALYSIS

-1.3%

1 Week

Low

High

2845.2

2980

5.5%

1 Month

Low

High

2570.45

2980

14.17%

3 Months

Low

High

2489.3

2980

31.58%

6 Months

Low

High

2113.8

2980

53.73%

1 Year

Low

High

1772.05

2980

Bigul
13 Jun 2024

Torrent Pharma slips 3% after USFDA issues 5 observations for Indrad Unit

The fall came after the United States Food and Drug Administration (USFDA) issued a Form 483 with five observations for the Indrad unit
Bigul
05 Jun 2024

Torrent Pharmaceuticals secured licensing agreement with Takeda, shares up

The Indian market for GERD treatments is valued at 8,064 crore, with an 8% CAGR over the last four years, based on AWACS MAT April 2024 data
Bigul
05 Jun 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

Torrent Pharmaceuticals Enters into Non-Exclusive Patent Licensing Agreement with Takeda Pharmaceuticals to Commercialize its Novel Gastrointestinal Drug in India
Bigul
30 May 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

Transcript of Conference Call with Analysts / Investors on Audited Financial Results for the quarter and year ended 31st March, 2024
Bigul
29 May 2024

TORRENT PHARMACEUTICALS LTD. - 500420 - Announcement under Regulation 30 (LODR)-Newspaper Publication

Copies of Newspaper cuttings in connection with transfer of shares to IEPF.
27 May 2024

Torrent Pharma Q4 Results Review - Another Quarter Of Strong Margins: Prabhdas Lilladher

Guided for $250-300 million US revenues in next three-five years.
27 May 2024

Torrent Pharma Shares Hit Record On Post Result Target Price Hikes

Brokerage firm Citi has raised the stock's target price to Rs 3,000 from Rs 2,960 earlier while maintaining its 'buy' rating.
See all News

FAQs

The latest market price of Torrent Pharmaceuticals Ltd. on NSE was Rs. 2856.00 as of today.

The opening share price of Torrent Pharmaceuticals Ltd. was Rs. 2899.80 as of today.

The 52-week high share price of Torrent Pharmaceuticals Ltd. was Rs. 2980.00.

The 52 week low share price of Torrent Pharmaceuticals Ltd. was Rs. 1772.00.

Torrent Pharmaceuticals Ltd. has a market cap of Rs. 96660.00 crore as of today. Please refer to the Fundamentals section for further details.

The PE ratio of Torrent Pharmaceuticals Ltd. is 1.70. Please refer to the Fundamentals section for further details.

The operating revenue for Torrent Pharmaceuticals Ltd. in the last FY was Rs.  10728.00 crore. Please refer to the Financials section for further details.

The Net Profit for Torrent Pharmaceuticals Ltd. in the last FY was Rs. 1656.00 crore. Please refer to the Financials section for further details.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

Please refer to Stock Ants, Bigul’s Community Access platform that aggregates tips and research from experts and provides real-time tracking to help investors validate, discover new investment ideas, and make informed decisions. Click here to learn more.

The latest dividend declared by Torrent Pharmaceuticals Ltd. was on 2024-06-21 for Rs. 6 per share. According to today’s share price, the dividend yield of Torrent Pharmaceuticals Ltd. stands at 1.10. Please refer to the Corporate Actions section for further details.

The latest bonus issue declared by Torrent Pharmaceuticals Ltd. was as of 2022-07-08. The bonus ratio declared in this issue was 1:1. Please refer to the Corporate Actions section for further details.

The latest split issue declared by Torrent Pharmaceuticals Ltd. was as of 2006-02-20. The split ratio declared in this issue was 10:5. Please refer to the Corporate Actions section for further details.

Please refer to Bigul Traders Corner, One Stop destination for different algo and non-algo trading strategies and tools meant for investors, traders, and strategists. Our qualified experts with rich experience in broking, financial analysis, and software development designed it in-house. Click here to learn more.

Please refer to JARVIS, which is Bigul’s AI Portfolio Manager Tool that uses artificial intelligence algorithms to make investment decisions in a portfolio. Click here to learn more.

Please refer to the News section for the latest news about Torrent Pharmaceuticals Ltd..

Close

Let's Open Free Demat Account